ESTUDOS
CLÍNICOS
Conheça alguns os estudos clínicos que já foram ou estão sendo realizados pela Science Valley:
TRATAMENTO
VALERIA TRIAL
Venous Thromboembolism Prophylaxis After Gynecological Pelvic Cancer Surgery With Rivaroxaban vs Enoxaparin (VALERIA)
ClinicalTrials.gov Identifier:
NCT04999176
SAIBA +
TRATAMENTO
COMPASS CLAUDICATION TRIAL
Rivaroxaban 2.5 mg BID and Aspirin for Intermittent Claudication in PAD Patients
ClinicalTrials.gov Identifier:
NCT04853719
SAIBA +
TRATAMENTO
VICTORION-2P TRIAL
Study of Inclisiran to Prevent Cardiovascular (CV) Events in Participants With Established Cardiovascular Disease (VICTORION-2P)
ClinicalTrials.gov Identifier:
NCT05030428
SAIBA +
TRATAMENTO
CRT-090 TRIAL
Hyperbaric Novabupi® in Spinal Anesthesia in Lower Limbs Vascular Surgery
ClinicalTrials.gov Identifier:
NCT03883763
SAIBA +
TRATAMENTO
CHARM TRIAL
Phase 3 Study to Evaluate the Efficacy and Safety of Intravenous BIIB093 (Glibenclamide) for Severe Cerebral Edema Following Large Hemispheric Infarction (CHARM)
ClinicalTrials.gov Identifier:
NCT02864953
SAIBA +
TRATAMENTO
MICHELLE
Medically Ill Hospitalized Patients for COVID-19 THrombosis Extended ProphyLaxis With Rivaroxaban ThErapy
ClinicalTrials.gov Identifier:
NCT04662684
SAIBA + BAIXE O ESTUDO
TRATAMENTO
STRUCK TRIAL
Survival Trial Using CytoKines
ClinicalTrials.gov Identifier:
NCT04724629
SAIBA +
TRATAMENTO
BTK
Study of the Safety and Efficacy of STI-5656 (Abivertinib Maleate) in Subjects Hospitalized Due to COVID-19
ClinicalTrials.gov Identifier:
NCT04528667
SAIBA +
TRATAMENTO
COMET-ICE
VIR-7831 for the Early Treatment of COVID-19 in Outpatients
ClinicalTrials.gov Identifier:
NCT04545060
SAIBA +
PORTFÓLIO ESTRATÉGICO
AGRIPPA
Efficacy and Safety of Apixaban in Reducing Restenosis and Limb Loss in PAD Patients
ClinicalTrials.gov Identifier:
NCT04229264